Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials.
- 2022-08-26
- Systematic Review
- Frontiers in pharmacology 13
- Ning Dai
- Fang-Fang Zhao
- Min Fang
- Feng-Lan Pu
- Ling-Yao Kong
- Jian-Ping Liu
- PubMed: 36091752
- DOI: 10.3389/fphar.2022.917521
- High evidence
- Clinical
GP was inferior to red yeast rice in TC (MD 0.64 mmol/L, 95% CI 0.15-1.13), TG (MD 0.43 mmol/L, 95% CI 0.15-0.71), and HDL-C (MD -0.25 mmol/L, 95% CI -0.47 to -0.04).
- Effect
- Harmful
- Effect size
- Small
- Significant
- Yes